hepatocellular carcinoma

Open Access
Cytoplasmic Expression of the EGFL6 Protein Is an Independent Prognostic Factor for Shortened Patient Survival in Human Hepatocellular Carcinoma
HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG

In Vivo September 2024, 38 (5) 2455-2463; DOI: https://doi.org/10.21873/invivo.13715
Open Access
Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA

In Vivo September 2024, 38 (5) 2501-2505; DOI: https://doi.org/10.21873/invivo.13721
Open Access
Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO and KENTA MOTOMURA

In Vivo July 2024, 38 (4) 1854-1858; DOI: https://doi.org/10.21873/invivo.13639
Open Access
Clinicopathologic Significance of Quaking Expression in Hepatocellular Carcinoma
SUNG-EUN KIM, CHEOL KEUN PARK, JI WON PARK, JUNG WOO LEE, JI-YOUNG CHOE and YOON AH CHO

In Vivo July 2024, 38 (4) 2064-2073; DOI: https://doi.org/10.21873/invivo.13665
Open Access
Proton-beam Therapy for Locally Advanced Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus: Case Report
SHINTARO SHIBA, SACHIKA SHIRAISHI, KOICHI TOKUUYE, RYOSUKE SHIRATA and MOTOKO OMURA

In Vivo July 2024, 38 (4) 2080-2084; DOI: https://doi.org/10.21873/invivo.13667
Open Access
Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma
HUI-TING HSU, YUEH-MIN LIN, MING-TAI HSING, KUN-TU YEH, JENG-WEI LU and SHUN-FA YANG

In Vivo May 2024, 38 (3) 1316-1324; DOI: https://doi.org/10.21873/invivo.13571
Open Access
Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model
JR-DI YANG, YU-CHANG LIU, HSIAO-CHIA WANG, FEI-TING HSU, TSAI LAN LIAO, MENG-CHU HUANG and JIANN-HWA CHEN

In Vivo May 2024, 38 (3) 1079-1093; DOI: https://doi.org/10.21873/invivo.13542
Open Access
Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells
HIRAYUKI ENOMOTO, TAKASHI NISHIMURA, SHINYA FUKUNUSHI, HIDEYUKI SHIOMI and HIROKO IIJIMA

In Vivo September 2023, 37 (5) 1975-1979; DOI: https://doi.org/10.21873/invivo.13294
Open Access
Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases
TOSHIHIKO MOTOHARA, KENSUKE YAMAMURA, HIDEAKI MIYAMOTO, SHIGENORI UENO, HIROSHI TAKENO, YASUNORI NAGAYAMA, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, TAKATOSHI ISIKO and TORU BEPPU

In Vivo September 2023, 37 (5) 2268-2275; DOI: https://doi.org/10.21873/invivo.13329
Open Access
The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer
FERNANDA VILLARRUEL-MELQUIADES, ELIZABETH HERNANDEZ-GALLEGOS, CARMEN SOLANO-AGAMA, MARIA EUGENIA MENDOZA-GARRIDO and JAVIER CAMACHO

In Vivo May 2023, 37 (3) 1156-1163; DOI: https://doi.org/10.21873/invivo.13190

Main menu

User menu

Search

hepatocellular carcinoma

Pages